Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis

Figure 2

Mean percentage of EPCs before and after 3 months of anti-TNF treatment. EPCs: endothelial progenitor cells.